RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents.

Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents.

Add to Collection
2022 Sep 15 Others BD Mohammad, MS Baig, N Bhandari, FA Siddiqui… - Molecules, 2022 - mdpi.com

Full Author : ['Mohammad, Badrud Duza', 'Baig, Mirza Shahed', 'Bhandari, Neeraj', 'Siddiqui, Falak A', 'Khan, Sharuk L', 'Ahmad, Zubair', 'Khan, Farhat S', 'Tagde, Priti', 'Jeandet, Philippe']
Journal Title : Molecules (Basel, Switzerland)
Chapter : Section4
Journal Year : 2022
Cited by : 6

Dipeptidyl peptidase-IV (DPP-IV) inhibitors, often known as gliptins, have been used to treat type 2 diabetes mellitus (T2DM). They may be combined with other medications as an additional treatment or used alone as a monotherapy. In addition to insulin, s..... Read More

Keywords : ['potent antidiabetic agent', 'dipeptidyl peptidaseiv inhibitor', 'special emphasis', 'heterocyclic compound', 'oxadiazole']
PubMed Link : https://www.mdpi.com/1420-3049/27/18/6001
Google Scholar Link : https://scholar.google.com/scholar?cites=8372196341687701851&as_sdt=5,33&sciodt=0,33&hl=en&num=20